CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
, preferred stock, and certificates of deposit can provide investors with reliable returns that are less susceptible to volatility and a hedge against uncertain times. “Bonds can serve as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results